FEZZA, FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 21.028
AS - Asia 2.129
EU - Europa 1.812
SA - Sud America 299
Continente sconosciuto - Info sul continente non disponibili 129
AF - Africa 31
OC - Oceania 6
Totale 25.434
Nazione #
US - Stati Uniti d'America 20.948
SG - Singapore 1.007
CN - Cina 435
IT - Italia 309
RU - Federazione Russa 274
UA - Ucraina 258
BR - Brasile 254
DE - Germania 225
HK - Hong Kong 203
IE - Irlanda 184
VN - Vietnam 151
FR - Francia 120
SE - Svezia 102
BD - Bangladesh 98
PL - Polonia 95
GB - Regno Unito 92
FI - Finlandia 61
KR - Corea 61
JP - Giappone 60
CA - Canada 39
IN - India 29
MX - Messico 21
AR - Argentina 19
BE - Belgio 16
ES - Italia 15
CZ - Repubblica Ceca 13
NL - Olanda 13
ZA - Sudafrica 13
EC - Ecuador 10
JM - Giamaica 9
IQ - Iraq 8
TR - Turchia 8
EU - Europa 6
HU - Ungheria 6
ID - Indonesia 6
IL - Israele 6
IR - Iran 6
KG - Kirghizistan 6
VE - Venezuela 6
AU - Australia 5
MY - Malesia 5
TH - Thailandia 5
AT - Austria 4
GR - Grecia 4
JO - Giordania 4
PH - Filippine 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CR - Costa Rica 3
GT - Guatemala 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
OM - Oman 3
PK - Pakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
SC - Seychelles 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
HN - Honduras 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 25.313
Città #
Woodbridge 5.873
Wilmington 5.458
Houston 4.722
Fairfield 673
Singapore 630
Ann Arbor 481
Chandler 370
Ashburn 358
Seattle 274
Jacksonville 247
San Jose 232
Cambridge 223
Hong Kong 197
Beijing 183
Dublin 180
Medford 145
Dearborn 121
Santa Clara 106
Los Angeles 94
New York 93
Kraków 78
The Dalles 76
Lawrence 66
Council Bluffs 60
Rome 57
Tokyo 50
Ho Chi Minh City 49
Hanoi 44
Moscow 39
Mülheim 39
Buffalo 36
Dallas 34
San Diego 31
Menlo Park 28
Munich 28
Milan 27
Lauterbourg 26
São Paulo 26
Chicago 21
Boardman 16
Brussels 16
London 16
San Mateo 16
Warsaw 15
Orem 13
Chennai 12
Montreal 12
Phoenix 12
Verona 12
Atlanta 11
Brno 11
Naples 11
Zhengzhou 11
Columbus 10
Nuremberg 10
Toronto 10
Brooklyn 9
Johannesburg 9
Redondo Beach 9
Redwood City 9
Frankfurt am Main 8
Hefei 8
San Francisco 8
Seoul 8
Shanghai 8
Boston 7
Cagliari 7
Curitiba 7
Kingston 7
Kunming 7
Mexico City 7
Nanjing 7
Poplar 7
Rio de Janeiro 7
Saint Petersburg 7
Charlotte 6
Detroit 6
Falls Church 6
Fortaleza 6
Palo Alto 6
Bari 5
Berlin 5
Bologna 5
Cangzhou 5
Catania 5
Da Nang 5
Denver 5
Guangzhou 5
Haiphong 5
Helsinki 5
North Bergen 5
Tucson 5
University Park 5
Amman 4
Auburn Hills 4
Baghdad 4
Campinas 4
Dhaka 4
Guayaquil 4
Hamilton 4
Totale 21.958
Nome #
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase 535
Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity 515
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake 507
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 495
Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction 490
Mouse blastocyts release a lipid which activates anandamide hydrolase in intact uterus 485
Endocannabinoids, related compounds and their metabolic routes 476
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid 469
The anandamide membrane transporter and the therapeutic implications of its inhibition 469
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. 466
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins 465
Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases. 465
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 464
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 462
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. 456
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol 455
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation 451
Differential regulation of fatty acid amide hydrolase promoter in human immune cells and neuronal cells by leptin and progesterone 450
Evidence for the intracellular accumulation of anandamide in adiposomes 441
Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two. 440
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors 439
New insights into endocannabinoid degradation and its therapeutic potential 438
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 437
Methods to assay anandamide hydrolysis and transport in synaptosomes. 437
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 437
Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system 436
Levels of N-Acylethanolamines in Human Tumors: In Search of Reliable Data 435
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 434
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties. 433
Endocannabinoid biochemistry: What do we know after 50 years? 431
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol 430
Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system. 427
Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system. 423
Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. 423
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. 423
Endocannabinoids and their involvement in the neurovascular system. 422
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 421
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17 beta-estradiol 419
Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes 417
Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor. 417
Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus 410
Pitfalls and solutions in assaying anandamide transport in cells. 409
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 400
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. 400
The endocannabinoid system in neurodegeneration. 400
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells: Implications for anandamide-induced apoptosis 399
null 393
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 392
Rat and human fatty acid amide hydrolases: overt similarities and hidden differences. 386
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells 379
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism 369
Regulation of endocannabinoid system by lipid rafts along the neuroimmune axis 276
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 270
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 228
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 194
The endocannabinoid hydrolase FAAH is an allosteric enzyme 178
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 162
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 160
Assay of NAPE-PLD Activity 153
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 138
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 127
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 126
Bisphenol A deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin B production 114
Plant-Derived and Endogenous Cannabinoids in Epilepsy 113
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs 107
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 93
Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 88
Fatty acid amide hydrolase, anandamide, and neurological diseases 80
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 77
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 75
Radiometric Assay of NAPE-PLD Activity 75
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 71
Endocannabinoids and platelets - Signalling pathways 69
Endocannabinoids and platelets - Differentiation 50
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models 38
Totale 25.434
Categoria #
all - tutte 59.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022643 0 80 37 22 18 44 36 19 52 74 45 216
2022/2023930 108 82 45 123 70 203 61 59 83 4 68 24
2023/2024230 37 11 11 17 18 55 6 9 10 3 13 40
2024/20251.462 74 348 194 90 25 111 127 72 105 116 133 67
2025/20262.625 213 122 291 205 282 85 314 334 266 191 217 105
2026/2027268 212 56 0 0 0 0 0 0 0 0 0 0
Totale 25.434